Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer von Niemeijer, A. N., Leung, D., Huisman, M. C., Bahce, I., Hoekstra, O. S., van Dongen, G. A. M. S., Boellaard, R., Du, S., Hayes, W., Smith, R., Windhorst, A. D., Hendrikse, N. H., Poot, A., Vugts, D. J., Thunnissen, E., Morin, P., Lipovsek, D., Donnelly, D. J., Bonacorsi, S. J., Velasquez, L. M., de Gruijl, T. D., Smit, E. F., de Langen, A. J.

Volltext

[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer von van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C. T., Dekker, H., van Dongen, G. A. M. S., Vugts, D. J., Boellaard, R., van Herpen, C. M. L., de Vries, E. G. E., Oyen, W. J. G., Brouwers, A. H., Verheul, H. M. W., Hoekstra, O. S., Menke-van der Houven van Oordt, C. W.

Volltext

Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer von Ankersmit, M., Hoekstra, O. S., van Lingen, A., Bloemena, E., Jacobs, M. A. J. M., Vugts, D. J., Bonjer, H. J., van Dongen, G. A. M. S., Meijerink, W. J. H. J.

Volltext

Sentinel node procedure of the sigmoid using indocyanine green: feasibility study in a goat model von van der Pas, M. H. G. M., van Dongen, G. A. M. S., Cailler, F., Pèlegrin, A., Meijerink, W. J. H. J.

Volltext

89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study von Linders, D. G. J., Deken, M. M., van Dam, M. A., Wasser, M. N. J. M., Voormolen, E. M. C., Kroep, J. R., van Dongen, G. A. M. S., Vugts, D., Oosterkamp, H. M., Straver, M. E., van de Velde, C. J. H., Cohen, D., Dibbets-Schneider, P., van Velden, F. H. P., Pereira Arias-Bouda, L. M., Vahrmeijer, A. L., Liefers, G. J., de Geus-Oei, L. F., Hilling, D. E.

Volltext

Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer von van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C. T., Dekker, H., van Dongen, G. A. M. S., Vugts, D. J., Boellaard, R., van Herpen, C. M. L., de Vries, E. G. E., Oyen, W. J. G., Brouwers, A. H., Verheul, H. M. W., Hoekstra, O. S., der Houven van Oordt, C. W. Menke-van

Volltext

Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models von El-Emir, E, Dearling, J L J, Huhalov, A, Robson, M P, Boxer, G, Neri, D, van Dongen, G A M S, Trachsel, E, Begent, R H J, Pedley, R B

Volltext

Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET von Bahce, I, Yaqub, M, Smit, E.F, Lammertsma, A.A, van Dongen, G.A.M.S, Hendrikse, N.H

Volltext

Application of 89Zr-DFO-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody von Stergiou, N., Wuensche, T. E., Schreurs, M., Mes, I., Verlaan, M., Kooijman, E. J. M., Windhorst, A. D., Helboe, L., Vergo, S., Christensen, S., Asuni, A. A., Jensen, A., Van Dongen, G. A. M. S., Bang-Andersen, B., Vugts, D. J., Beaino, W.

Volltext

Photosensitizer-antibody conjugates for detection and therapy of cancer von van Dongen, G.A.M.S, Visser, G.W.M, Vrouenraets, M.B

Volltext

In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma von Nestor, M, Persson, M, van Dongen, G A M S, Jensen, H J, Lundqvist, H, Anniko, M, Tolmachev, V

Volltext

Imaging of TKI-Target Interactions for Personalized Cancer Therapy von Poot, A J, Slobbe, P, Hendrikse, N H, Windhorst, A D, van Dongen, GAMS

Volltext

How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients von Tijink, B.M., De Bree, R., Van Dongen, G.A.M.S., Leemans, C.R.

Volltext

Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study von Linders, D. G. J, Deken, M. M, van Dam, M. A, Wasser, M. N. J. M, Voormolen, E. M. C, Kroep, J. R, van Dongen, G. A. M. S, Vugts, D, Oosterkamp, H. M, Straver, M. E, van de Velde, C. J. H, Cohen, D, Dibbets-Schneider, P, van Velden, F. H. P, Pereira Arias-Bouda, L. M, Vahrmeijer, A. L, Liefers, G. J, de Geus-Oei, L. F, Hilling, D. E

Volltext

[Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer von van Helden, E J, Elias, S G, Gerritse, S L, van Es, S C, Boon, E, Huisman, M C, van Grieken, N C T, Dekker, H, van Dongen, G A M S, Vugts, D J, Boellaard, R, van Herpen, C M L, de Vries, E G E, Oyen, W J G, Brouwers, A H, Verheul, H M W, Hoekstra, O S, Menke-van der Houven van Oordt, C W

Volltext

Radioimmunodiagnosis of lymph node metastases in head and neck cancer von de Bree, R, Roos, JC, Verel, I, van Dongen, GAMS, Snow, GB

Volltext

Application of 89 Zr-DFO-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody von Stergiou, N, Wuensche, T E, Schreurs, M, Mes, I, Verlaan, M, Kooijman, E J M, Windhorst, A D, Helboe, L, Vergo, S, Christensen, S, Asuni, A A, Jensen, A, Van Dongen, G A M S, Bang-Andersen, B, Vugts, D J, Beaino, W

Volltext

Public―private partnerships in translational medicine: Concepts and practical examples: Drug Delivery Research in Europe von LUIJTEN, P. R, DONGEN, G. A. M. S. Van, MOONEN, C. T, STORM, G, CROMMELIN, D. J. A

Volltext

Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice von VAN GOG, F. B, BRAKENHOFF, R. H, SNOW, G. B, VAN DONGEN, G. A. M. S

Volltext

Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy von VROUENRAETS, M. B, VISSER, G. W. M, STEWART, F. A, STIGTER, M, OPPELAAR, H, POSTMUS, P. E, SNOW, G. B, VAN DONGEN, G. A. M. S

Volltext